Results 131 to 140 of about 508,912 (302)
Human Tumor Immunology and Molecular Biology from Basic Research to Clinical Application [PDF]
openalex +1 more source
A Twist in the Diagnosis: Chronic Arthropathy Without Inflammation
Arthritis Care &Research, EarlyView.
María Á. Puche‐Larrubia +3 more
wiley +1 more source
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen +14 more
wiley +1 more source
BACKGROUND Cow’s milk (CM) allergy is the most common food allergy in young children. Treatment with oral immunotherapy (OIT) has shown efficacy, but high rates of adverse reactions.
Jennifer A. Dantzer +9 more
doaj +1 more source
Clinical immunology Flow cytometric characteristics of alveolar lymphocytes (AL) obtained from the control group – proposal of normal value range of AL subsets in nonsmokers [PDF]
Piotr Kopiński +7 more
openalex
COVID-19: Clinical and Public Health Implications of SARS-CoV-2 Immunology
Christine Laine +2 more
openalex +2 more sources
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry +16 more
wiley +1 more source
BACKGROUND Inhibition of Bruton’s tyrosine kinase with ibrutinib blocks the function of myeloid-derived suppressor cells (MDSC). The combination of ibrutinib and nivolumab was tested in patients with metastatic solid tumors.METHODS Sixteen patients ...
Emily Schwarz +31 more
doaj +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source

